The effects of ingestion of Panax genus plants, extracts, or ginsenosides intake on muscle damage- A systematic review with Meta-analysis.
- Conditions
- Adult volunteers who have no problems with motor and metabolic functions.
- Registration Number
- JPRN-UMIN000046674
- Lead Sponsor
- Maruzen Pharmaceuticals Co., LTD.
- Brief Summary
Seven studies met the inclusion criteria. The number of participants was 201, with 105 in the ingestion-Panax genus plants(PGPs) group and 104 in the controlgroup, because including crossover-design trials. Ingestion of PGPs group significantly suppresses the elevated serum creatin kinase(CK) 72 hours after exercise (SMD, 0.58; 95% CI, 0.22-0.95) but with a high I2 value (I2=91%), and not 60 min or 24 hours.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 201
Not provided
Literature which does not meet key inclusion criteria will be excluded. Participants who are planning or currently pregnant or breastfeeding, and children (persons under 18 years), will be excluded from this study. If participants have conditions such as any acute or chronic disease which impact their physical exercise ability or their serum creatine kinase: central nervous system, muscular, cardiovascular, pulmonary, endocrine system, gastrointestinal system, and other organ dysfunction, or cancer, they will be excluded. The studies will be excluded from using special dosage form food like foods to avoid digestion or absorption by the gastrointestinal system as intervention foods. For the control group, no intervention is excluded. Literature not written in English or Japanese will be excluded due to inability to verify and perform data extraction.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method